Novavax and Serum Institute of India Announce Development and Commercial Collaboration
August 06, 2020 16:49 ET
|
Novavax, Inc.
Expected to support minimum of 1 billion doses of NVX-CoV2373 for India and low- and middle-income countriesLeverages Serum Institute’s existing reach and infrastructure Builds on and complements...
Novavax to Host Conference Call to Discuss Second Quarter Financial and Operating Results on August 10, 2020
August 06, 2020 06:45 ET
|
Novavax, Inc.
GAITHERSBURG, Md., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
August 04, 2020 16:05 ET
|
Novavax, Inc.
Phase 1 portion of the Phase 1/2 clinical trial evaluated two doses of Novavax’ COVID-19 vaccine across two dose levels (5 and 25 µg) in 131 healthy adults ages 18-59 yearsNVX-CoV2373 was generally...
Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
July 23, 2020 16:02 ET
|
Novavax, Inc.
GAITHERSBURG, Md. and MORRISVILLE, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious...
Novavax to Present COVID-19 Vaccine Candidate Progress at 2nd ISV COVID-19 Vaccines Virtual Congress
July 20, 2020 16:05 ET
|
Novavax, Inc.
GAITHERSBURG, Md., July 20, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces $1.6 Billion Funding from Operation Warp Speed
July 07, 2020 06:00 ET
|
Novavax, Inc.
Funding supports late-stage clinical development, including pivotal Phase 3 clinical trial to support licensure OWS award funds large-scale manufacturing of NVX-CoV2373, including production of 100...
Novavax Announces Updates to Leadership Team
July 02, 2020 08:30 ET
|
Novavax, Inc.
Frank Czworka appointed SVP, Global Sales Brian Webb promoted to SVP, Manufacturing GAITHERSBURG, Md., July 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology...
Novavax Expands Executive Leadership and Announces Key Promotions
June 29, 2020 08:42 ET
|
Novavax, Inc.
GAITHERSBURG, Md., June 29, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax to Participate in H.C. Wainwright Fireside Chat Series
June 24, 2020 08:00 ET
|
Novavax, Inc.
GAITHERSBURG, Md., June 24, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
Novavax Announces Additions to Executive Leadership
June 17, 2020 08:00 ET
|
Novavax, Inc.
GAITHERSBURG, Md., June 17, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...